Birkir Thor Bragason

Birkir Thor Bragason

Auto-generated profile, based on publicly available information

Birkir Thor Bragason

Institute for Experimental Pathology, University of Iceland, Keldur V. Vesturlandsveg, 112 Reykjavik, Iceland

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 1999 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
RAReynir Arngrímsson
Reynir Arngrímsson
SSSigrún Siguróaróóttir
Sigrún Siguróaróóttir
MFMichael L. Frigge
Michael L. Frigge
RBRagnheióur I. Bjarnaóóttir
Ragnheióur I. Bjarnaóóttir
TJThorlákur Jónsson
Thorlákur Jónsson
KSKári Stefánsson
Kári Stefánsson
Pre-eclampsia is a common and serious disease and a major cause of maternal and infant mortality. Antenatal care systems world-wide screen for signs of the disease such as hypertension and proteinuria. Unlike most other human disorders it impacts two individuals, the mother and the child, both of whom can be severely affected. The pathophysiology of the disorder is incompletely understood, but familial clustering of the disease is apparent. Here we report the results of a genome-wide screen of Icelandic families representing 343 affected women. Including those patients with non-proteinuric pre-eclampsia (gestational hypertension), proteinuric pre-eclampsia and eclampsia, we detected a significant locus on 2p13 with a lod score of 4.70 (single point P<3.49 × 10−6). This is the first reported locus for pre-eclampsia meeting the criteria for genome-wide significance.

1 October 2018 in Developmental & Comparative Immunology
Verified
Journal Article
Open access
BMBergljót Magnadóttir
Bergljót Magnadóttir
PHPolly Hayes
Polly Hayes
MHMariya Hristova
Mariya Hristova
BBBirkir Thor Bragason
Birkir Thor Bragason
ANAnthony P Nicholas
Anthony P Nicholas
Sigrun LangeSigrun Lange
Sigrun Lange
Peptidylarginine deiminases (PADs) are calcium dependent enzymes with physiological and pathophysiological roles conserved throughout phylogeny. PADs promote post-translational deimination of protein arginine to citrulline, altering the structure and function of target proteins. Deiminated proteins were detected in the early developmental stages of cod from 11 days post fertilisation to 70 days post hatching. Deiminated proteins were present in mucosal surfaces and in liver, pancreas, spleen, gut, muscle, brain and eye during early cod larval development. Deiminated protein targets identified in skin mucosa included nuclear histones; cytoskeletal proteins such as tubulin and beta-actin; metabolic and immune related proteins such as galectin, mannan-binding lectin, toll-like receptor, kininogen, Beta2-microglobulin, aldehyde dehydrogenase, bloodthirsty and preproapolipoprotein A-I. Deiminated histone H3, a marker for anti-pathogenic neutrophil extracellular traps, was particularly elevated in mucosal tissues in immunostimulated cod larvae. PAD-mediated protein deimination may facilitate protein moonlighting, allowing the same protein to exhibit a range of biological functions, in tissue remodelling and mucosal immune defences in teleost ontogeny.

1 October 2018 in Developmental & Comparative Immunology
Verified
Journal Article
Open access
BMBergljót Magnadóttir
Bergljót Magnadóttir
PHPolly Hayes
Polly Hayes
BGBerglind Gísladóttir
Berglind Gísladóttir
BBBirkir Þór Bragason
Birkir Þór Bragason
MHMariya Hristova
Mariya Hristova
Sigrun LangeSigrun Lange
Sigrun Lange
Pentraxins are fluid phase pattern recognition molecules that form an important part of the innate immune defence and are conserved between fish and human. In Atlantic cod (Gadus morhua L.), two pentraxin-like proteins have been described, CRP-I and CRP-II. Here we show for the first time that these two CRP forms are post-translationally deiminated (an irreversible conversion of arginine to citrulline) and differ with respect to tissue specific localisation in cod ontogeny from 3 to 84 days post hatching. While both forms are expressed in liver, albeit at temporally differing levels, CRP-I shows a strong association with nervous tissue while CRP-II is strongly associated to mucosal tissues of gut and skin. This indicates differing roles for the two pentraxin types in immune responses and tissue remodelling, also elucidating novel roles for CRP-I in the nervous system. The presence of deimination positive bands for cod CRPs varied somewhat between mucus and serum, possibly facilitating CRP protein moonlighting, allowing the same protein to exhibit a range of biological functions and thus meeting different functional requirements in different tissues. The presented findings may further current understanding of the diverse roles of pentraxins in teleost immune defences and tissue remodelling, as well as in various human pathologies, including autoimmune diseases, amyloidosis and cancer.

1 March 2019 in Developmental & Comparative Immunology
Verified
Journal Article
Open access
BMBergljót Magnadóttir
Bergljót Magnadóttir
BBBirkir Thor Bragason
Birkir Thor Bragason
IBIan R. Bricknell
Ian R. Bricknell
Tim BowdenTim Bowden
Tim Bowden
ANAnthony P Nicholas
Anthony P Nicholas
Sigrun LangeSigrun Lange
Sigrun Lange
Post-translational protein deimination is mediated by peptidylarginine deiminases (PADs), which are calcium dependent enzymes conserved throughout phylogeny with physiological and pathophysiological roles. Protein deimination occurs via the conversion of protein arginine into citrulline, leading to structural and functional changes in target proteins. In a continuous series of early halibut development from 37 to 1050° d, PAD, total deiminated proteins and deiminated histone H3 showed variation in temporal and spatial detection in various organs including yolksac, muscle, skin, liver, brain, eye, spinal cord, chondrocytes, heart, intestines, kidney and pancreas throughout early ontogeny. For the first time in any species, deimination of complement components C3 and C4 is shown in halibut serum, indicating a novel mechanism of complement regulation in immune responses and homeostasis. Proteomic analysis of deiminated target proteins in halibut serum further identified complement components C5, C7, C8 C9 and C1 inhibitor, as well as various other immunogenic, metabolic, cytoskeletal and nuclear proteins. Post-translational deimination may facilitate protein moonlighting, an evolutionary conserved phenomenon, allowing one polypeptide chain to carry out various functions to meet functional requirements for diverse roles in immune defences and tissue remodelling.

20 June 2008 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
APAstridur Palsdottir
Astridur Palsdottir
AHAgnar Helgason
Agnar Helgason
SPSnæbjörn Pálsson
Snæbjörn Pálsson
HBHans Tomas Bjornsson
Hans Tomas Bjornsson
BBBirkir Thor Bragason
Birkir Thor Bragason
KSKari Stefansson
Kari Stefansson
Hereditary cystatin C amyloid angiopathy (HCCAA) is an autosomal dominant disease with high penetrance, manifest by brain hemorrhages in young normotensive adults. In Iceland, this condition is caused by the L68Q mutation in the cystatin C gene, with contemporary carriers reaching an average age of only 30 years. Here, we report, based both on linkage disequilibrium and genealogical evidence, that all known copies of this mutation derive from a common ancestor born roughly 18 generations ago. Intriguingly, the genealogies reveal that obligate L68Q carriers born 1825 to 1900 experienced a drastic reduction in life span, from 65 years to the present-day average. At the same time, a parent-of-origin effect emerged, whereby maternal inheritance of the mutation was associated with a 9 year reduction in life span relative to paternal inheritance. As these trends can be observed in several different extended families, many generations after the mutational event, it seems likely that some environmental factor is responsible, perhaps linked to radical changes in the life-style of Icelanders during this period. A mutation with such radically different phenotypic effects in reaction to normal variation in human life-style not only opens the possibility of preventive strategies for HCCAA, but it may also provide novel insights into the complex relationship between genotype and environment in human disease. This work focuses on the L68Q mutation in the cystatin C gene which causes hereditary cystatin C amyloid angiopathy (HCCAA), an autosomal dominant disease with high penetrance in contemporary Icelanders, manifest by lethal brain hemorrhages in young normotensive adults. On the basis of both DNA haplotype and genealogical analyses, we determined that all known copies of the L68Q mutation derive from a common ancestor born roughly 18 generations ago, around 1550. Furthermore, we were able to show a rapid change in its penetrance for obligate carriers born from 1825 to 1900, demonstrated by a drastic reduction in life span, from 65 years to the present-day average of 30 years. The detrimental phenotypic impact of the L68Q mutation appears to have emerged in reaction to common life-style changes almost three centuries after the mutation occurred. We believe that this is the first report of phenotypic flexibility of a monogenic disease in reaction to life-style changes that fall within the normal range of behavior of a single population in the space of a few generations. Our results underline how single gene disorders with simple Mendelian inheritance can be affected by environmental factors, resulting in changed disease status.

30 June 2005 in Molecular and Cellular Neuroscience
Verified
Journal Article
Closed access
BBBirkir Thor Bragason
Birkir Thor Bragason
APAstridur Palsdottir
Astridur Palsdottir